Mastino, A <br/><br/>
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.  [electronic resource] 

 -  International journal of cancer  Feb 1992 
 - 493-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.2910500327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma--drug therapy<br/>Cell Division--drug effects<br/>Cyclophosphamide--administration & dosage<br/>Cytotoxicity, Immunologic--drug effects<br/>Interleukin-2--administration & dosage<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasms, Experimental--drug therapy<br/>Spleen--cytology<br/>Thymalfasin<br/>Thymosin--administration & dosage